NCT03073993

Brief Summary

Enteral feeding tubes in newborns are used for feeding preterm and low birth weight babies in neonatal intensive care units as they often do not suck effectively owing to lack of coordination between sucking, swallowing and breathing due to neurological immaturity and delayed gastric emptying. The feeding tubes could be inserted by the nasogastric (NG) route or by the orogastric (OG) route. Both routes are used in different Neonatal Intensive Care Units (NICUs). Both methods are associated with different adverse events. Since newborn infants are obligate nose breathers, nasogastric tube (NGT) can lead to partial nasal obstruction which might increase airway resistance and work of breathing although they are easy to secure to the face than orally placed tubes. Orogastric tubes (OGT), on the other hand, may not lead to the potential risk of increased work of breathing associated with NGT but are more frequently malpositioned and can loop inside the mouth. Also there is increased possibility of apnea and bradycardia due to vagal stimulation. Despite so many years of continuing debate, the evidence of superiority of one method over another is not proven. Very few studies have tried to look into this matter and there are no consensus guidelines. This study is being conducted to compare the rate and type of adverse events in OG versus NG feeds in preterm neonates ≤ 32 weeks and postmenstrual age (PMA) ≤ 36 weeks. Preterm neonates born at ≤ 32 weeks with PMA≤ 36 weeks who require feeding tube as a route for enteral feeding once they are out of respiratory support ( i.e ventilation or CPAP) are eligible candidates. Feeding tube insertion episode (FTIE) is defined as episode of insertion of OG or NG tube. FTIE will be randomized into NG or OG routes. Primary outcome is frequency of desaturation and bradycardia in each group.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
160

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2015

Shorter than P25 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2015

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2016

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

August 2, 2016

Completed
7 months until next milestone

First Posted

Study publicly available on registry

March 8, 2017

Completed
Last Updated

March 8, 2017

Status Verified

March 1, 2017

Enrollment Period

8 months

First QC Date

August 2, 2016

Last Update Submit

March 2, 2017

Conditions

Keywords

nasogastricorogastricnutritionpretermfeeding tubeinsertionepisodesbradycardiadesaturation

Outcome Measures

Primary Outcomes (1)

  • Heart rate and saturation

    frequency of episodes of heart rate \<100 and sauration \< 85%

    48 hours

Secondary Outcomes (1)

  • infant feeding tube

    48 hours

Study Arms (2)

Nasogastric

ACTIVE COMPARATOR

Feeding tube insertion in nasogastric group

Procedure: feeding tube insertion

Orogastric

ACTIVE COMPARATOR

Feeding tube insertion in orogastric group

Procedure: feeding tube insertion

Interventions

Feeding tube was inserted in hemodynamically stable babies for purpose of feeding

NasogastricOrogastric

Eligibility Criteria

Age25 Weeks - 32 Weeks
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Hemodynamically stable preterm neonates (≤32 weeks gestational age and PMA ≤ 36weeks) not requiring respiratory support (CPAP/Heated humidified high flow oxygen/ Ventilation).

You may not qualify if:

  • Babies (\> 32 weeks and PMA\>36 weeks)
  • Severe congenital malformations, chromosomal abnormalities
  • Baby requiring any respiratory support
  • Sepsis, IVH, NEC or any illness explaining apneas

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Bohnhorst B, Cech K, Peter C, Doerdelmann M. Oral versus nasal route for placing feeding tubes: no effect on hypoxemia and bradycardia in infants with apnea of prematurity. Neonatology. 2010;98(2):143-9. doi: 10.1159/000279617. Epub 2010 Mar 16.

    PMID: 20234138BACKGROUND

MeSH Terms

Conditions

Premature BirthBradycardia

Interventions

Intubation, Gastrointestinal

Condition Hierarchy (Ancestors)

Obstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesArrhythmias, CardiacHeart DiseasesCardiovascular DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

IntubationTherapeuticsInvestigative Techniques

Study Officials

  • Naveen P Gupta, MD, DNB

    Consultant Neonatologist

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
DNB Resident in Pediatrics

Study Record Dates

First Submitted

August 2, 2016

First Posted

March 8, 2017

Study Start

October 1, 2015

Primary Completion

June 1, 2016

Study Completion

June 1, 2016

Last Updated

March 8, 2017

Record last verified: 2017-03

Data Sharing

IPD Sharing
Will not share